Iran Develops Cancer Treatment With No Foreign Equivalent

Oncopore G2121 uses precisely controlled electric pulses to dramatically increase chemotherapy absorption by cancer cells, while minimizing damage to healthy tissue.

Key Features:

Iranian engineers developed more than 17 proprietary probes, including designs for vaginal, oral, liver and pancreatic tumors, which have no known foreign equivalentsMore than 2,000 patients have already been treated, while peer-reviewed studies reported high response rates and minimal side effectsThe system costs half as much as imported alternatives and is already in use at Iranian hospitals

The breakthrough marks another step toward strengthening Iranian medical and technological self-reliance while expanding advanced cancer care across the region.

Source: https://sputnikglobe.com